You are here

Pieris

Pieris wields axe after losing AZ as partner for elarekibep

Pharmaphorum

Wed, 07/19/23 - 10:13 am

Pieris stock deflates as AstraZeneca stops trials of asthma drug in response to toxicology signal

Fierce Biotech

Wed, 06/21/23 - 10:54 am

clinical trials

3 Biotechs That Will Soar Regardless of COVID-19

Motley Fool

Thu, 01/27/22 - 11:39 pm

Sana Biotechnology

Pieris finally vaults FDA hold on next-gen solid tumor hunter, clearing the path for mid-stage trial

Endpoints

Thu, 01/21/21 - 10:47 am

Pieris begins gastric cancer combination trial with Lilly’s Cyramza

Pharmaforum

Tue, 08/11/20 - 11:41 am

The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down

Yahoo/Benzinga

Sun, 11/17/19 - 08:47 pm

The Medicines Company

SITC – the morning after the night before

EP Vantage

Mon, 11/11/19 - 07:51 pm

SITC 2019 preview – Pieris joins the quest for a better Herceptin

EP Vantage

Mon, 11/4/19 - 07:22 pm

Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup

Endpoints

Thu, 05/11/17 - 11:41 am

Pieris, AstraZeneca ink $45m deal for inhaled respiratory drugs

Drug Delivery Business News

Thu, 05/4/17 - 09:43 am

Biotechs line up for a busy week of IPOs

Fierce Biotech

Mon, 06/22/15 - 11:17 am

Seres Therapeutics

Pieris and Sanofi Broaden Existing Collaboration

Yahoo

Wed, 04/10/13 - 11:06 am